Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Lucas Wiessing, Marica Ferri, Bart Grady, Maria Kantzanou, Ida Sperle, Katelyn J. Cullen, EMCDDA DRID Group, Angelos Hatzakis, Maria Prins, Peter Vickerman, Jeffrey V. Lazarus, Vivian D. Hope, Catharina Mathei, Sharon Hutchinson

Research output: Contribution to journalArticle

156 Downloads (Pure)

Abstract

People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.
Original languageEnglish
Article numbere103345
Number of pages20
JournalPLoS ONE
Volume9
Issue number7
DOIs
Publication statusPublished - 28 Jul 2014

Keywords

  • people who inject drugs
  • PWID
  • hepatitis C
  • HCV epidemiology
  • Europe

Fingerprint Dive into the research topics of 'Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention'. Together they form a unique fingerprint.

  • Cite this

    Wiessing, L., Ferri, M., Grady, B., Kantzanou, M., Sperle, I., Cullen, K. J., EMCDDA DRID Group, Hatzakis, A., Prins, M., Vickerman, P., Lazarus, J. V., Hope, V. D., Mathei, C., & Hutchinson, S. (2014). Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS ONE , 9(7), [e103345]. https://doi.org/10.1371/journal.pone.0103345